Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2713250rdf:typepubmed:Citationlld:pubmed
pubmed-article:2713250lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C0201553lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:2713250lifeskim:mentionsumls-concept:C1546922lld:lifeskim
pubmed-article:2713250pubmed:issue4lld:pubmed
pubmed-article:2713250pubmed:dateCreated1989-6-15lld:pubmed
pubmed-article:2713250pubmed:abstractTextIn 101 breast cancer patients, measurement of oestrogen receptor status in multiple biopsies across a tumour reveals a highly significant difference in the proportion of patients remaining either disease-free (P less than 0.04) or alive (P less than 0.005), when those with uniformly receptor positive (++) primary tumours are matched with clinically comparable patients whose tumours were homogeneously receptor negative (--). Mean follow-up time was 85 months. The prognostic value of this discriminant is particularly striking in the 53 patients with involved nodes at presentation. Of these, 13 were (++) and seven remain alive of whom six are disease-free, whereas 24 of the 29 (--) patients are dead. These results further suggest that receptor assay on a single homogenate gives less clinical information than do assays on multiple biopsies across the tumour. For patients with involved nodes, clinical management may best be decided after determination of 'macroheterogeneity'.lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:languageenglld:pubmed
pubmed-article:2713250pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:citationSubsetIMlld:pubmed
pubmed-article:2713250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2713250pubmed:statusMEDLINElld:pubmed
pubmed-article:2713250pubmed:monthAprlld:pubmed
pubmed-article:2713250pubmed:issn0007-0920lld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:LeakeRRlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:Di CarloAAlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:MesitiMMlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:CastagnettaLLlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:CarrubaGGlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:Lo CastoMMlld:pubmed
pubmed-article:2713250pubmed:authorpubmed-author:TrainaAAlld:pubmed
pubmed-article:2713250pubmed:issnTypePrintlld:pubmed
pubmed-article:2713250pubmed:volume59lld:pubmed
pubmed-article:2713250pubmed:ownerNLMlld:pubmed
pubmed-article:2713250pubmed:authorsCompleteYlld:pubmed
pubmed-article:2713250pubmed:pagination636-8lld:pubmed
pubmed-article:2713250pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:meshHeadingpubmed-meshheading:2713250-...lld:pubmed
pubmed-article:2713250pubmed:year1989lld:pubmed
pubmed-article:2713250pubmed:articleTitleDo multiple oestrogen receptor assays give significant additional information for the management of breast cancer?lld:pubmed
pubmed-article:2713250pubmed:affiliationHormone Biochemistry Laboratory, School of Medicine, University of Palermo-Policlinico, Italy.lld:pubmed
pubmed-article:2713250pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2713250pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed